Contact us

  • View funds and model portfolios

    Learn more about our investment products

    How to invest with us

  • Latest insights""Events and webinars""Vanguard outlook 2026""
  • Discover Vanguard 365""

    Learn and earn CPD

    In-depth research for advisers

    Tools and resources for advisers

  • About Vanguard""Contact us""Fraud prevention""

    Corporate reports

    • Contact us

    FTSE Developed Europe ex-U.K. Equity Index Fund - GBP Acc (VDEXEIA)

    Available in other share classes
    Related Documents
    NAV Price ()
    —
    Number of stocks
    —
    —
    Risk Indicator
    —

    About this fund

    Fund objectives

    • The Fund is a passive fund.
    • The Fund seeks to track the performance of the FTSE Developed Europe ex U.K. Index (the “Index”).
    • The Index is comprised of large and mid-sized company shares in developed markets in Europe, excluding the UK.
    • The Fund attempts to: 1. Track the performance of the Index by investing in all constituent shares of the Index in the same proportion as the Index. 2. Remain fully invested invested and hold small amounts of cash except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy.

    Fund facts

    Share class inception
    23 Jun 2009
    Minimum initial investment
    £1,000,000.00
    Investment structure
    UK OEIC
    Share Class Assets'
    Total Assets
    Strategy
    Index
    Asset Class
    Equity
    Domicile
    United Kingdom
    Dividend schedule
    —
    Tax status
    —
    Currency
    GBP
    Legal entity
    Vanguard® Investments Funds ICVC
    Investment manager

    Vanguard Asset Management, Ltd.
    Europe Equity Index Team

    Benchmark
    FTSE Developed Europe ex-U.K. Index

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Performance

    Risk and Volatility

    As at 30 Nov 2025

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 424 409 30 Nov 2025
    Median market capital 59.9 B 59.9 B 30 Nov 2025
    16.8 x 16.8 x 30 Nov 2025
    2.3 x 2.3 x 30 Nov 2025
    13.3% 13.3% 30 Nov 2025
    14.9% 14.9% 30 Nov 2025
    Portfolio turnover rate -1.3% — 31 Oct 2025

    Market allocation

    As at 30 Nov 2025

    CountryRegionFundBenchmarkVariance +/-
    FranceEurope 19.86% 20.92% -1.06%
    SwitzerlandEurope 18.91% 18.94% -0.03%
    GermanyEurope 18.44% 18.34% 0.10%
    NetherlandsEurope 9.21% 9.22% -0.01%
    SpainEurope 7.34% 7.35% -0.01%
    ItalyEurope 6.90% 6.91% -0.01%
    SwedenEurope 6.59% 6.60% -0.01%
    DenmarkEurope 3.58% 3.59% -0.01%
    BelgiumEurope 2.22% 2.22% 0.00%
    FinlandEurope 2.20% 2.21% -0.01%
    NorwayEurope 1.11% 1.11% 0.00%
    OtherOther 1.03% 0.00% 1.03%
    PolandEurope 0.86% 0.86% 0.00%
    IrelandEurope 0.69% 0.69% 0.00%
    AustriaEurope 0.65% 0.65% 0.00%

    Holdings details

    As at 30 Nov 2025

    Holding name% of market valueSectorRegionMarket valueShares
    ASML Holding NV 3.97085% Technology NL £239,213,974.02 302,314
    Roche Holding AG 2.59116% Health Care CH £156,098,052.41 540,254
    Nestle SA 2.42057% Consumer Staples CH £145,820,879.06 1,943,381
    SAP SE 2.39435% Technology DE £144,241,883.29 789,647
    Novartis AG 2.33876% Health Care CH £140,892,466.99 1,434,693
    Siemens AG 1.87206% Industrials DE £112,777,492.74 563,986
    LVMH Moet Hennessy Louis Vuitton SE 1.80988% Consumer Discretionary FR £109,031,411.21 195,879
    Allianz SE 1.60634% Financials DE £96,769,674.78 296,755
    Banco Santander SA 1.53033% Financials ES £92,190,641.17 11,387,429
    Novo Nordisk A/S 1.51026% Health Care DK £90,981,613.41 2,447,330

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or futures contracts.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and equity index derivatives.

    Prices and distribution

    Prices

    NAV Price (GBP)
    £487.49
    Change
    +£1.450.30%
    At closure 06 Jan 2026
    NAV 52-week high
    £487.49
    At closure 07 Jan 2026
    NAV 52-week low
    £371.18
    At closure 07 Jan 2026
    NAV 52-week difference
    £116.31
    Change
    +23.86%
    At closure 07 Jan 2026
    Historical Prices

    -

    Inception date

    23 Jun 2009

    Date NAV (GBP)
    06 Jan 2026 £487.4857
    05 Jan 2026 £486.0334
    02 Jan 2026 £483.5405
    31 Dec 2025 £481.4883
    30 Dec 2025 £481.4762
    29 Dec 2025 £478.1417
    24 Dec 2025 £477.7944
    23 Dec 2025 £478.4556
    22 Dec 2025 £477.3185
    19 Dec 2025 £479.2885

    Distribution history

    Distribution frequency

    —

    Historical performance 30 Nov 2025

    2.36%

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currency

    Base currency: GBP

    Fund codes

    • Bloomberg: VDEXEIA
    • Citi: FPD1
    • ISIN: GB00B5B71H80
    • MEX ID: VVDEEU
    • SEDOL: B5B71H8

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.